Goff MCF Partners, LP 4/A
Accession 0000899243-19-030128
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:13 PM ET
Size
60.6 KB
Accession
0000899243-19-030128
Insider Transaction Report
- Other
Common Stock
2019-12-19+8,533,072→ 10,846,008 total(indirect: See footnote) - Other
Common Stock
2019-12-19−7,832,710→ 14,400,595 total(indirect: See footnote) - Other
Common Stock
2019-12-19−172,890→ 11,687,805 total(indirect: See footnote) - Other
Common Stock
2019-12-19−691,556→ 10,857,938 total(indirect: See footnote) - Other
Common Stock
2019-12-19−69,156→ 10,270,115 total(indirect: See footnote) - Other
Common Stock
2019-12-19−9,211→ 10,153,230 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,145,862 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+800,000$2,000,000→ 800,000 total(indirect: See footnote)→ Common Stock (800,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+200,000$500,000→ 200,000 total(indirect: See footnote)→ Common Stock (200,000 underlying) - Other
Common Stock
2019-12-19+2,539,900→ 2,612,664 total(indirect: See footnote) - Other
Common Stock
2019-12-19+172,890→ 172,890 total(indirect: See footnote) - Other
Common Stock
2019-12-19−2,539,900→ 11,860,695 total(indirect: See footnote) - Other
Common Stock
2019-12-19−103,733→ 10,754,205 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,546,738 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+820,000$2,050,000→ 820,000 total(indirect: See footnote)→ Common Stock (820,000 underlying) - Other
Common Stock
2019-12-19−138,311→ 11,549,494 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,339,271 total(indirect: See footnote) - Other
Common Stock
2019-12-19−106,937→ 10,163,178 total(indirect: See footnote) - Other
Common Stock
2019-12-19−1,842→ 10,144,020 total(indirect: See footnote) - Other
Common Stock
2019-12-19+7,832,710→ 7,832,710 total(indirect: See footnote) - Other
Common Stock
2019-12-19−8,533,072→ 22,233,305 total(indirect: See footnote) - Other
Common Stock
2019-12-19−737→ 10,162,441 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,149,546 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+400,000$1,000,000→ 400,000 total(indirect: See footnote)→ Common Stock (400,000 underlying)
- 3,571,786
Common Stock
- 16,082
Common Stock
- Other
Common Stock
2019-12-19+7,832,710→ 7,832,710 total(indirect: See footnote) - Other
Common Stock
2019-12-19+8,533,072→ 10,846,008 total(indirect: See footnote) - Other
Common Stock
2019-12-19−8,533,072→ 22,233,305 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,145,862 total(indirect: See footnote) - Other
Common Stock
2019-12-19−103,733→ 10,754,205 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,546,738 total(indirect: See footnote) - Other
Common Stock
2019-12-19−106,937→ 10,163,178 total(indirect: See footnote) - Other
Common Stock
2019-12-19−1,842→ 10,144,020 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+820,000$2,050,000→ 820,000 total(indirect: See footnote)→ Common Stock (820,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+800,000$2,000,000→ 800,000 total(indirect: See footnote)→ Common Stock (800,000 underlying) - Other
Common Stock
2019-12-19+2,539,900→ 2,612,664 total(indirect: See footnote) - Other
Common Stock
2019-12-19+172,890→ 172,890 total(indirect: See footnote) - Other
Common Stock
2019-12-19−138,311→ 11,549,494 total(indirect: See footnote) - Other
Common Stock
2019-12-19−69,156→ 10,270,115 total(indirect: See footnote) - Other
Common Stock
2019-12-19−2,539,900→ 11,860,695 total(indirect: See footnote) - Other
Common Stock
2019-12-19−7,832,710→ 14,400,595 total(indirect: See footnote) - Other
Common Stock
2019-12-19−172,890→ 11,687,805 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,339,271 total(indirect: See footnote) - Other
Common Stock
2019-12-19−9,211→ 10,153,230 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,149,546 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+200,000$500,000→ 200,000 total(indirect: See footnote)→ Common Stock (200,000 underlying) - Other
Common Stock
2019-12-19−691,556→ 10,857,938 total(indirect: See footnote) - Other
Common Stock
2019-12-19−737→ 10,162,441 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+400,000$1,000,000→ 400,000 total(indirect: See footnote)→ Common Stock (400,000 underlying)
- 3,571,786
Common Stock
- 16,082
Common Stock
- Other
Common Stock
2019-12-19+172,890→ 172,890 total(indirect: See footnote) - Other
Common Stock
2019-12-19−2,539,900→ 11,860,695 total(indirect: See footnote) - Other
Common Stock
2019-12-19−103,733→ 10,754,205 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,546,738 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,339,271 total(indirect: See footnote) - Other
Common Stock
2019-12-19+7,832,710→ 7,832,710 total(indirect: See footnote) - Other
Common Stock
2019-12-19−7,832,710→ 14,400,595 total(indirect: See footnote) - Other
Common Stock
2019-12-19−172,890→ 11,687,805 total(indirect: See footnote) - Other
Common Stock
2019-12-19−691,556→ 10,857,938 total(indirect: See footnote) - Other
Common Stock
2019-12-19−8,533,072→ 22,233,305 total(indirect: See footnote) - Other
Common Stock
2019-12-19−69,156→ 10,270,115 total(indirect: See footnote) - Other
Common Stock
2019-12-19−737→ 10,162,441 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,145,862 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+400,000$1,000,000→ 400,000 total(indirect: See footnote)→ Common Stock (400,000 underlying) - Other
Common Stock
2019-12-19−106,937→ 10,163,178 total(indirect: See footnote) - Other
Common Stock
2019-12-19−9,211→ 10,153,230 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,149,546 total(indirect: See footnote) - Other
Common Stock
2019-12-19−1,842→ 10,144,020 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+820,000$2,050,000→ 820,000 total(indirect: See footnote)→ Common Stock (820,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+800,000$2,000,000→ 800,000 total(indirect: See footnote)→ Common Stock (800,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+200,000$500,000→ 200,000 total(indirect: See footnote)→ Common Stock (200,000 underlying) - Other
Common Stock
2019-12-19+8,533,072→ 10,846,008 total(indirect: See footnote) - Other
Common Stock
2019-12-19+2,539,900→ 2,612,664 total(indirect: See footnote) - Other
Common Stock
2019-12-19−138,311→ 11,549,494 total(indirect: See footnote)
- 3,571,786
Common Stock
- 16,082
Common Stock
- Other
Common Stock
2019-12-19+8,533,072→ 10,846,008 total(indirect: See footnote) - Other
Common Stock
2019-12-19+172,890→ 172,890 total(indirect: See footnote) - Other
Common Stock
2019-12-19−8,533,072→ 22,233,305 total(indirect: See footnote) - Other
Common Stock
2019-12-19−103,733→ 10,754,205 total(indirect: See footnote) - Other
Common Stock
2019-12-19−737→ 10,162,441 total(indirect: See footnote) - Other
Common Stock
2019-12-19+7,832,710→ 7,832,710 total(indirect: See footnote) - Other
Common Stock
2019-12-19−2,539,900→ 11,860,695 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,546,738 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,145,862 total(indirect: See footnote) - Other
Common Stock
2019-12-19−1,842→ 10,144,020 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+800,000$2,000,000→ 800,000 total(indirect: See footnote)→ Common Stock (800,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+200,000$500,000→ 200,000 total(indirect: See footnote)→ Common Stock (200,000 underlying) - Other
Common Stock
2019-12-19+2,539,900→ 2,612,664 total(indirect: See footnote) - Other
Common Stock
2019-12-19−172,890→ 11,687,805 total(indirect: See footnote) - Other
Common Stock
2019-12-19−691,556→ 10,857,938 total(indirect: See footnote) - Other
Common Stock
2019-12-19−106,937→ 10,163,178 total(indirect: See footnote) - Other
Common Stock
2019-12-19−9,211→ 10,153,230 total(indirect: See footnote) - Other
Common Stock
2019-12-19−7,832,710→ 14,400,595 total(indirect: See footnote) - Other
Common Stock
2019-12-19−138,311→ 11,549,494 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+820,000$2,050,000→ 820,000 total(indirect: See footnote)→ Common Stock (820,000 underlying) - Other
Common Stock
2019-12-19−207,467→ 10,339,271 total(indirect: See footnote) - Other
Common Stock
2019-12-19−69,156→ 10,270,115 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,149,546 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+400,000$1,000,000→ 400,000 total(indirect: See footnote)→ Common Stock (400,000 underlying)
- 3,571,786
Common Stock
- 16,082
Common Stock
- Other
Common Stock
2019-12-19+8,533,072→ 10,846,008 total(indirect: See footnote) - Other
Common Stock
2019-12-19−7,832,710→ 14,400,595 total(indirect: See footnote) - Other
Common Stock
2019-12-19−691,556→ 10,857,938 total(indirect: See footnote) - Other
Common Stock
2019-12-19−103,733→ 10,754,205 total(indirect: See footnote) - Other
Common Stock
2019-12-19−9,211→ 10,153,230 total(indirect: See footnote) - Other
Common Stock
2019-12-19−1,842→ 10,144,020 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+820,000$2,050,000→ 820,000 total(indirect: See footnote)→ Common Stock (820,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+800,000$2,000,000→ 800,000 total(indirect: See footnote)→ Common Stock (800,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+200,000$500,000→ 200,000 total(indirect: See footnote)→ Common Stock (200,000 underlying) - Other
Common Stock
2019-12-19+7,832,710→ 7,832,710 total(indirect: See footnote) - Other
Common Stock
2019-12-19−2,539,900→ 11,860,695 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,339,271 total(indirect: See footnote) - Other
Common Stock
2019-12-19−106,937→ 10,163,178 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,145,862 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+400,000$1,000,000→ 400,000 total(indirect: See footnote)→ Common Stock (400,000 underlying) - Other
Common Stock
2019-12-19+172,890→ 172,890 total(indirect: See footnote) - Other
Common Stock
2019-12-19−172,890→ 11,687,805 total(indirect: See footnote) - Other
Common Stock
2019-12-19−138,311→ 11,549,494 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,546,738 total(indirect: See footnote) - Other
Common Stock
2019-12-19−69,156→ 10,270,115 total(indirect: See footnote) - Other
Common Stock
2019-12-19−737→ 10,162,441 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,149,546 total(indirect: See footnote) - Other
Common Stock
2019-12-19+2,539,900→ 2,612,664 total(indirect: See footnote) - Other
Common Stock
2019-12-19−8,533,072→ 22,233,305 total(indirect: See footnote)
- 3,571,786
Common Stock
- 16,082
Common Stock
- Other
Common Stock
2019-12-19−3,684→ 10,149,546 total(indirect: See footnote) - Other
Common Stock
2019-12-19−1,842→ 10,144,020 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+820,000$2,050,000→ 820,000 total(indirect: See footnote)→ Common Stock (820,000 underlying) - Other
Common Stock
2019-12-19−2,539,900→ 11,860,695 total(indirect: See footnote) - Other
Common Stock
2019-12-19−172,890→ 11,687,805 total(indirect: See footnote) - Other
Common Stock
2019-12-19−138,311→ 11,549,494 total(indirect: See footnote) - Other
Common Stock
2019-12-19−103,733→ 10,754,205 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,339,271 total(indirect: See footnote) - Other
Common Stock
2019-12-19−106,937→ 10,163,178 total(indirect: See footnote) - Other
Common Stock
2019-12-19−9,211→ 10,153,230 total(indirect: See footnote) - Other
Common Stock
2019-12-19+2,539,900→ 2,612,664 total(indirect: See footnote) - Other
Common Stock
2019-12-19+172,890→ 172,890 total(indirect: See footnote) - Other
Common Stock
2019-12-19−7,832,710→ 14,400,595 total(indirect: See footnote) - Other
Common Stock
2019-12-19+8,533,072→ 10,846,008 total(indirect: See footnote) - Other
Common Stock
2019-12-19+7,832,710→ 7,832,710 total(indirect: See footnote) - Other
Common Stock
2019-12-19−8,533,072→ 22,233,305 total(indirect: See footnote) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+400,000$1,000,000→ 400,000 total(indirect: See footnote)→ Common Stock (400,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+800,000$2,000,000→ 800,000 total(indirect: See footnote)→ Common Stock (800,000 underlying) - Purchase
Series C Contingent Convertible Preferred Stock
2019-12-19$2.50/sh+200,000$500,000→ 200,000 total(indirect: See footnote)→ Common Stock (200,000 underlying) - Other
Common Stock
2019-12-19−691,556→ 10,857,938 total(indirect: See footnote) - Other
Common Stock
2019-12-19−207,467→ 10,546,738 total(indirect: See footnote) - Other
Common Stock
2019-12-19−69,156→ 10,270,115 total(indirect: See footnote) - Other
Common Stock
2019-12-19−737→ 10,162,441 total(indirect: See footnote) - Other
Common Stock
2019-12-19−3,684→ 10,145,862 total(indirect: See footnote)
- 16,082
Common Stock
- 3,571,786
Common Stock
Footnotes (10)
- [F1]These securities are held directly by the the John C. Goff 2010 Family Trust (the Trust). John C. Goff is the trustee of the Trust and, as such, he may be deemed to beneficially own the securities held by the Trust.
- [F10]The Series C Preferred Stock has no expiration date.
- [F2]These securities are held directly by Goff Family Investments, LP (Goff Investments). Goff Capital, Inc. (Goff Capital) is the general partner of Goff Investments and, as such, it may be deemed to beneficially own the securities held by Goff Investments. The Trust is the controlling shareholder of Goff Capital and, as such, it may be deemed to beneficially own the securities held by Goff Capital. John C. Goff is the trustee of the Trust and, as such, he may be deemed to beneficially own the securities held by the Trust.
- [F3]These securities are held directly by JCG 2016 Holdings, LP (JCG Holdings). JCG 2016 Management, LLC (JCG Management) is the general partner of JCG Holdings and, as such, it may be deemed to beneficially own the securities held by JCG Holdings. John C. Goff is the manager of JCG Management, and, as such, he may be deemed to beneficially own the securities held by JCG Management.
- [F4]These securities are held directly by Kulik Partners, LP (Kulik Partners). Kulik GP, LLC (Kulik GP) is the general partner of Kulik Partners and, as such, may be deemed to beneficially own the securities held by Kulik Partners. John C. Goff is the manager of Kulik GP, and, as such, he may be deemed to beneficially own the securities held by Kulik GP.
- [F5]The Common Stock directly held by John C. Goff. The Common Stock was issued directly to Mr. Goff in connection with his service as a member of the board of directors of the Issuer.
- [F6]These securities are held directly by Goff MCF Partners, LP (Goff MCF). GFS Contango GP, LLC (GFS Contango) is the general partner of Goff MCF, and, as such, it may be deemed to beneficially own the securities held by Goff MCF. GFS Management, LLC (GFS Management) is the managing member of GFS Contango and, as such, it may be deemed to beneficially own the securities held by GFS Contango. Goff Focused Strategies LLC (GFS) is the managing member of GFS Management and, as such, it may be deemed to beneficially own the securities held by GFS Management. GFT Strategies, LLC (GFT) is the controlling equity holder of GFS and, as such, it may be deemed to beneficially own the securities held by GFS. The Trust is the managing member of GFT and, as such, it may be deemed to beneficially own the securities held by GFT. John C. Goff is the trustee of the Trust and, as such, he may be deemed to beneficially own the securities held by the Trust.
- [F7]Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Goff MCF to its limited partners. Each of the Trust, Goff Investments, JCG Holdings and Kulik Partners received shares of Common Stock from Goff MCF in connection with the distribution.
- [F8]Prior to the disposition, these securities were held directly by Goff MCF.
- [F9]The Series C Preferred Stock is convertible into shares of Common Stock on a one-for-one basis upon the approval by the shareholders of the Issuer, in accordance with applicable law and the applicable rules and regulations of the principal national securities exchange on which the Common Stock is listed for trading.
Documents
Issuer
CONTANGO OIL & GAS CO
CIK 0001071993
Related Parties
1- filerCIK 0001743422
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 7:13 PM ET
- Size
- 60.6 KB